Earnings beat and guidance hike put CareTrust REIT (CTRE) in focus

CareTrust REIT (CTRE) has drawn fresh attention after reporting first quarter 2026 earnings and revenue that topped expectations and prompted management to raise full year guidance for key cash flow metrics.

Despite the upbeat first quarter 2026 report and a stronger acquisition pipeline in the U.K., recent momentum has cooled, with the share price down 12.69% over the past 30 days and 8.19% over 90 days, even as the 1 year total shareholder return of 31.93% and 3 year total shareholder return of 112.51% point to a much stronger longer term picture.

If this kind of mixed near term momentum and stronger long term total shareholder return has you comparing opportunities, it could be a good time to widen your search using the 20 top founder-led companies

With the stock down in recent months yet trading at what some valuation models suggest is a sizeable discount to intrinsic value, you have to ask: is this weakness a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 18.2% Undervalued

CareTrust REIT's most followed narrative anchors on a fair value of $44.91 per share, compared with the recent close at $36.75, which puts valuation front and center.

The expanded investment pipeline of approximately $600 million, mainly in skilled nursing, seniors housing, and U.K. care homes, gives visibility into continued external growth, bolstering FFO and supporting durable, long term dividend increases.

Want the full story behind that pipeline math and the fair value uplift? Revenue mix shifts, margin assumptions, and a higher future earnings multiple all play roles in that analysis.

Result: Fair Value of $44.91 (UNDERVALUED)

However, that fair value story can be challenged if rapid portfolio expansion stumbles on integration issues, or if higher G&A and regulatory pressures erode rent coverage and margins.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another angle on valuation: the earnings multiple

The SWS DCF model points to strong undervaluation, yet the P/E picture is more mixed. CareTrust REIT trades at 25.9x earnings, higher than the Global Health Care REITs average of 21.1x but below a fair ratio of 38.8x and well under a 53.8x peer average. Is the stock cheap, or just less expensive than even richer peers?

To see how that gap between current P/E, the sector, and the fair ratio could affect your margin of safety, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Still undecided after all this? With both risks and rewards in play, move quickly to review the full picture and weigh the 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

If this update has you rethinking your watchlist, now is the moment to broaden your horizons with fresh opportunities that match your goals and risk comfort.

• Target potential mispricing by scanning 46 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their underlying strength.
• Strengthen your income stream by reviewing 8 dividend fortresses that focus on higher yielding stocks with robust payout profiles.
• Sleep easier at night by checking 67 resilient stocks with low risk scores built around companies with more resilient risk scores and steadier financial foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.